Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CGONCGON
Showing 8 of 10 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CG ONCOLOGY INC

GEODE CAPITAL MANAGEMENT, LLC holds 2.2M shares of CGON (CG ONCOLOGY INC), worth $153M as of 2026-Q2. The position was increased (+34.8% shares). CGON represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$153M

Current Shares

2.2M

Total Value Change

+$112.3M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+34.8%
$153M0.0%$71.05
39
2026-Q1
Increased
1.6M
+5.7%
$108.1M0.0%$60.55
32
2025-Q4
Increased
1.5M
+2.6%
$62.8M0.0%$40.17
30
2025-Q3
Increased
1.5M
+10.3%
$59.4M0.0%$39.08
33
2025-Q2
Increased
1.3M
+4.4%
$34.7M0.0%$25.95
30
2025-Q1
Increased
1.3M
+10.6%
$31.3M0.0%$26.42
32
2024-Q4
Increased
1.2M
+7.3%
$33.2M0.0%$28.50
31
2024-Q3
Increased
1.1M
+96.2%
$40.7M0.0%$37.87
47

Other major holders of CGON: RTW INVESTMENTS, LP, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used